TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 46 filers reported holding TYRA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96,115 | -16.2% | 6,980 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $114,629 | +11.5% | 6,731 | +5.2% | 0.00% | 0.0% |
| Q1 2023 | $102,848 | +115.7% | 6,400 | +2.0% | 0.00% | – |
| Q4 2022 | $47,675 | -13.3% | 6,273 | +0.7% | 0.00% | – |
| Q3 2022 | $55,000 | +25.0% | 6,231 | +1.4% | 0.00% | – |
| Q2 2022 | $44,000 | -30.2% | 6,142 | +4.9% | 0.00% | – |
| Q1 2022 | $63,000 | -30.8% | 5,856 | -9.4% | 0.00% | – |
| Q4 2021 | $91,000 | – | 6,462 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $60,725,576 | 53.26% |
| Nextech Invest Ltd. | 2,518,582 | $34,680,874 | 10.51% |
| Boxer Capital, LLC | 6,448,359 | $88,793,903 | 4.73% |
| TCG Crossover Management, LLC | 1,989,103 | $27,389,948 | 4.03% |
| Fairmount Funds Management LLC | 1,393,329 | $19,186,140 | 2.31% |
| RA Capital Management | 7,236,454 | $99,645,972 | 1.96% |
| 5AM Venture Management, LLC | 411,450 | $5,665,667 | 1.63% |
| BVF INC/IL | 2,739,595 | $37,724,223 | 1.02% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $14,155,739 | 0.94% |
| Auour Investments LLC | 85,020 | $1,198,782 | 0.51% |